Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.0% during the fourth quarter, Holdings Channel reports. The firm owned 1,571,273 shares of the medical equipment provider’s stock after buying an additional 129,363 shares during the period. Intuitive Surgical comprises about 1.3% of Assenagon Asset Management S.A.’s holdings, making the stock its 11th largest position. Assenagon Asset Management S.A.’s holdings in Intuitive Surgical were worth $820,142,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter worth about $33,000. Mark Sheptoff Financial Planning LLC purchased a new position in Intuitive Surgical during the second quarter valued at approximately $37,000. Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the third quarter valued at $38,000. Finally, DT Investment Partners LLC lifted its holdings in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $538.88 on Wednesday. The stock has a market cap of $191.94 billion, a P/E ratio of 86.64, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. The firm has a 50 day moving average price of $537.05 and a two-hundred day moving average price of $496.50. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research raised their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Piper Sandler restated an “overweight” rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 3.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,190 shares of company stock valued at $25,012,927. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.